# REVIA
> **NDA018932** · New Drug Application · Sponsor: TEVA WOMENS · Approved 1984-11-20
## Drug
- **FDA Application Number:** NDA018932
- **Application type:** New Drug Application
- **Brand name:** REVIA
- **Generic name:** Naltrexone Hydrochloride
- **Active ingredients:** NALTREXONE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA WOMENS
- **First approval:** 1984-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018932)
---
*AI Analytics · CC0 1.0*